Clinical significance of SNRPD1 expression in predicting post-transplant recurrence of hepatocellular carcinoma
American Journal of Translational Research · 2026 · 18 (7) · 5547-5559
DOI: 10.62347/wjun3883 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Translational Research, 2026. Verfasst von Zhihong Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Fuzong Clinical Medical College of Fujian Medical University Fuzhou 350025, Fujian, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, Fuzong Clinical Medical College of Fujian Medical University Fuzhou 350025, Fujian, China.
- Department of Hepatobiliary Surgery, 900th Hospital of PLA Joint Logistic Support Force Fuzhou 350025, Fujian, China.
Zitieren
APA
Wei, Z., Lin, X., Chen, J., Zhu, W., Liu, J., Lv, L., & Yang, F. (2026). Clinical significance of SNRPD1 expression in predicting post-transplant recurrence of hepatocellular carcinoma. American Journal of Translational Research, 18(7), 5547-5559. https://doi.org/10.62347/wjun3883
Vancouver
Wei Z, Lin X, Chen J, Zhu W, Liu J, Lv L, et al. Clinical significance of SNRPD1 expression in predicting post-transplant recurrence of hepatocellular carcinoma. American Journal of Translational Research. 2026;18(7):5547-5559. doi:10.62347/wjun3883
BibTeX
@article{Wei2026,
author = {Wei, Zhihong and Lin, Xuanhua and Chen, Jianwei and Zhu, Weidong and Liu, Jianyong and Lv, Lizhi and Yang, Fang},
title = {Clinical significance of SNRPD1 expression in predicting post-transplant recurrence of hepatocellular carcinoma},
journal = {American Journal of Translational Research},
year = {2026},
volume = {18},
number = {7},
pages = {5547--5559},
doi = {10.62347/wjun3883}
}
EUVIMED